BioSpace News Archive

ScreenPro Security Inc. (CSE: SCRN) (OTCQB: SCRSF) (“ScreenPro” or the “Company”) is pleased to announce the Company’s financial results for the year ended December 31, 2022.

Cloud DX Inc. (TSXV: CDX) (OTCQB: CDXFF) (“Cloud” or the “Corporation”), is announcing that due to a short delay in finalizing the audit, the Corporation’s auditors have advised the Corporation that they do not anticipate being able to complete the necessary procedures

Tay Therapeutics, focused on developing small molecules for oncology and severe inherited diseases, today announced that it has entered into an exclusive license agreement with VYNE Therapeutics Inc. (Nasdaq: VYNE),

DirectSync Surgical, a medical device company dedicated to improving the lives of patients who suffer from spine and orthopedic diseases, has announced that its patient-powered smart spinal fusion device has received Breakthrough Device Designation by the US Food and Drug Administration.

Interactive Strength Inc. (FORME) (Nasdaq: TRNR), a digital fitness platform that combines premium connected fitness hardware products with personal training and coaching, today announced the closing of its initial public offering of an aggregate of 1,500,000 shares of its common stock at a price to the public of $8.00 per share.

Amyris, Inc. today announced that it will issue its financial results for the first quarter ended March 31, 2023, on the afternoon of Tuesday, May 9, 2023, after closing of the financial markets

Scorpion Therapeutics, Inc. today announced that the first patient has been dosed in a Phase 1/2 first-in-human dose escalation and expansion clinical trial evaluating STX-478.

Edgewise Therapeutics, Inc. announced today that management will participate in fireside chats at two upcoming investor conferences.

Avinger, Inc. today announced that it will release its financial results for the first quarter 2023 after the close of trading on Wednesday, May 10, 2023.

Nutcracker Therapeutics, Inc. will present at this year’s TIDES USA, or the Oligonucleotide and Peptide Therapeutics conference, being held May 7-10, 2023 in San Diego, CA.